These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8682023)

  • 1. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
    Erhardt L; MacLean A; Ilgenfritz J; Gelperin K; Blumenthal M
    Eur Heart J; 1995 Dec; 16(12):1892-9. PubMed ID: 8682023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group.
    Brown EJ; Chew PH; MacLean A; Gelperin K; Ilgenfritz JP; Blumenthal M
    Am J Cardiol; 1995 Mar; 75(8):596-600. PubMed ID: 7887385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure.
    Shettigar U; Hare T; Gelperin K; Ilgenfritz JP; Deitchman D; Blumenthal M
    Congest Heart Fail; 1999; 5(1):27-34. PubMed ID: 12189330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure.
    Davis R; Coukell A; McTavish D
    Drugs; 1997 Jul; 54(1):103-16. PubMed ID: 9211084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure. Fosinopril Hemodynamics Study Group.
    Sharma S; Deitchman D; Eni JS; Gelperin K; Ilgenfritz JP; Blumenthal M
    Am J Ther; 1999 Jul; 6(4):181-9. PubMed ID: 11329095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril.
    Galatius-Jensen S; Wroblewski H; Emmeluth C; Bie P; Haunsø S; Kastrup J
    Cardiovasc Res; 1996 Dec; 32(6):1148-54. PubMed ID: 9015418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure].
    Otasević P; Putiniković B; Vukajlović Z; Ilisić B; Nesković AN
    Med Pregl; 2006; 59(1-2):51-6. PubMed ID: 17068892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
    Zannad F; Chati Z; Guest M; Plat F
    Am Heart J; 1998 Oct; 136(4 Pt 1):672-80. PubMed ID: 9778071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
    Rouleau JL; Pfeffer MA; Stewart DJ; Isaac D; Sestier F; Kerut EK; Porter CB; Proulx G; Qian C; Block AJ
    Lancet; 2000 Aug; 356(9230):615-20. PubMed ID: 10968433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure.
    Kelbaek H; Agner E; Wroblewski H; Vasehus Madsen P; Marving J
    Eur Heart J; 1993 May; 14(5):692-5. PubMed ID: 8508863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
    Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
    J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atenolol as add-on therapy to fosinopril in heart failure.
    Pacher R; Hülsmann M; Berger R; Koller-Strametz J; Kos T; Frey B; Dukat A; Stanek B
    Wien Klin Wochenschr; 1997 Apr; 109(7):232-8. PubMed ID: 9141231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
    Littler WA; Sheridan DJ
    Br Heart J; 1995 May; 73(5):428-33. PubMed ID: 7786657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
    Colfer HT; Ribner HS; Gradman A; Hughes CV; Kapoor A; Laidlaw JC
    Am J Cardiol; 1992 Aug; 70(3):354-8. PubMed ID: 1632402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
    Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
    Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MERIT-HF mortality and morbidity data.
    Hjalmarson A; Fagerberg B
    Basic Res Cardiol; 2000; 95 Suppl 1():I98-103. PubMed ID: 11192362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.
    Borghi C; Marino P; Zardini P; Magnani B; Collatina S; Ambrosioni E
    Am Heart J; 1998 Aug; 136(2):213-25. PubMed ID: 9704681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.